Streetbeat News

Products Services

DIS

DKNG

For the first time, two Monday Night Football games will air simultaneously on Dec. 11, with the Tennessee Titans at Miami Dolphins on ESPN and the Green Bay Packers at New York Giants on ABC. Walt Disney Company (NYSE:DIS) holds the rights to these games, potentially boosting viewership. DraftKings Inc (NASDAQ:DKNG) has set betting odds for both games, favoring the Dolphins by 13.5 points and the Packers by 6 points. The Dolphins' strong season performance and feature on 'Hard Knocks' could attract new fans, while the Packers' perfect December record under Coach LaFleur may influence betting.

Portfolio Pulse from Chris Katje

December 11, 2023 | 10:06 pm

TM

Toyota Motor Corp (TM) is limiting sales at its dealerships in Japan due to difficulties in keeping up with the robust demand for its vehicles. The company is facing challenges in maintaining a stable supply of cars, which has led to this decision. Toyota's move to restrict sales aims to prevent long delivery times and maintain customer satisfaction. The company has not provided details on which models or regions are affected, or how long the limitations will last.

Portfolio Pulse from Charles Gross

December 11, 2023 | 10:01 pm

CMG

DPZ

SBUX

UBER

Benchmark analyst Todd Brooks upgraded Domino's Pizza Inc (NYSE:DPZ) from Hold to Buy with a price target of $455, citing potential growth from a revamped loyalty program and a nationwide launch on Uber Eats. Brooks compared Domino's technology platform favorably with industry leaders like Starbucks and Chipotle. He expects Domino's to achieve over 3% same store sales growth in the U.S. and highlighted management's forecasts for global retail sales and operating income growth. Domino's stock closed up 0.65% at $397.48 on Monday.

Portfolio Pulse from Adam Eckert

December 11, 2023 | 9:50 pm

AAPL

Apple Inc. has introduced a new 'Journal' app with the latest iOS 17.2 update, which allows users to create digital diaries using photos, videos, and audio. The app features machine learning, tailored prompts, and robust security with end-to-end encryption. Apple's stock saw a 1.4% decline on Monday, trading 2.7 percentage points below its all-time high.

Portfolio Pulse from Piero Cingari

December 11, 2023 | 9:42 pm

ADAUSD

BTCUSD

ETHUSD

Cardano (ADA) experienced a significant 8% decline, outpacing Bitcoin (BTC) and Ethereum (ETH) which both fell over 6%. ADA's open interest dropped by 14%, indicating a market outflow. Analyst Ali Martinez signaled a potential short-term correction for ADA. The Cardano community celebrated Ada Lovelace's 208th birthday, and the Cardano Foundation launched a self-sovereign Identity Wallet. Charles Hoskinson's post about his dog Freya inadvertently caused a rally in the Freya NFT project, which he later clarified he was not endorsing.

Portfolio Pulse from Khyathi Dalal

December 11, 2023 | 9:42 pm

ORCL

Oracle Corporation (NYSE:ORCL) reported Q2 earnings of $1.34 per share, beating estimates by $0.02, but missed revenue expectations with $12.94 billion against the forecasted $13.05 billion. Despite the revenue shortfall, Oracle highlighted a 25% increase in cloud revenue, with cloud infrastructure up 52% and cloud application revenue up 15%. The company's operating cash flow over the last twelve months was $17 billion, and free cash flow was $10.1 billion. CEO Safra Catz emphasized the growing demand for Cloud Infrastructure and Generative AI services, with Remaining Performance Obligations over $65 billion. After the report, ORCL shares dropped 8.91% in after-hours trading to $104.83.

Portfolio Pulse from Ryan Gustafson

December 11, 2023 | 9:40 pm

INAB

IN8bio's stock price has risen following the announcement of positive updated data from its Phase 1 trial of INB-100 for hematologic malignancies.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:35 pm

PFE

Pfizer has announced that the FDA has accepted its Biologics License Application for Marstacimab. Additionally, the European Marketing Authorization Application for Marstacimab has passed validation and is currently under review by the European Medicines Agency (EMA).

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:31 pm

MGRX

Mangoceuticals has entered into a marketing agreement with Marius Pharmaceuticals, according to a Dec. 10 SEC 8K filing. The agreement grants Mangoceuticals the rights to use the trademark 'Kyzatrex' for oral testosterone undecanoate softgel capsules and allows them to sell Kyzatrex on their website.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:30 pm

F

Ford Motor Co. is reportedly planning to cut production of its F-150 Lightning electric vehicle by half in 2024, according to a memo sent to suppliers. This decision could signal a shift in Ford's strategy or a response to market demand and supply chain issues.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:26 pm